Email Strategies for Commercial Independent Pharmacy Benefit Manager and Pharmacy Services Administration: Independent PBM and Transparent PBM Marketing, Specialty Pharmacy Accreditation and Network Inclusion, 340B Drug Pricing Program Administration and Compliance, Pharmacy Claims Adjudication and Switch Technology, Pharmacy Clinical Services and MTM (Medication Therapy Management), and Pharmacy Automation and Robotic Dispensing Technology
On this page
The Pharmacy Benefits Landscape
The pharmacy benefit management (PBM) industry is one of the most consequential and controversial sectors in American healthcare, sitting at the intersection of pharmaceutical manufacturers, health insurers, employers, pharmacies, and patients. PBMs manage prescription drug benefits for health plans, employers, and government programs, and their core functions include negotiating drug prices and rebates with pharmaceutical manufacturers, processing and adjudicating prescription claims at the point of sale, managing pharmacy networks (determining which pharmacies patients can use), developing and maintaining formularies (the lists of covered drugs and their tier placement that determine patient cost-sharing), and operating mail-order and specialty pharmacies.
The three largest PBMs -- CVS Caremark (part of CVS Health, which also owns Aetna insurance and CVS Pharmacy), Express Scripts (part of Cigna Group), and OptumRx (part of UnitedHealth Group, which also owns UnitedHealthcare insurance) -- collectively manage pharmacy benefits for approximately 75-80%+ of all commercially insured Americans and process billions of prescription claims annually. This concentration, combined with the vertical integration of these PBMs with health insurance companies, pharmacy chains, and specialty pharmacies, has drawn intense scrutiny from employers, legislators, state regulators, and the Federal Trade Commission (which has conducted investigations into PBM pricing practices and competitive behavior).
The scrutiny of the big three PBMs has created a significant market opportunity for independent and transparent PBMs -- companies like Capital Rx, RxBenefits, Navitus Health Solutions, Employers Health (EH), SmithRx, Rightway Healthcare, and others that offer pharmacy benefit management services with a different business model. Independent PBMs typically offer pass-through pricing (where the PBM passes through all manufacturer rebates, pharmacy discounts, and administrative fees to the plan sponsor with full transparency, earning revenue only from a disclosed administrative fee per claim), formulary independence (where the PBM's formulary decisions are based on clinical evidence and cost-effectiveness rather than on which manufacturer pays the highest rebates), and network flexibility (where the PBM constructs pharmacy networks based on performance and cost rather than on vertical integration with owned pharmacies).
Marketing Independent PBM Services to Employers
Employers are the primary buyers of PBM services in the commercial market, because most employer-sponsored health plans include a pharmacy benefit that is administered by a PBM. The employer's benefits director, CFO, or human resources VP makes the PBM selection decision (often with the assistance of a benefits consultant or broker), and this decision is typically reviewed every 3-5 years through a competitive RFP process. For independent PBMs, the sales cycle is long (6-18 months from initial contact to contract signing) and relationship-driven (employers rely heavily on their benefits consultants' recommendations).
The most effective email marketing approach for independent PBMs targeting employers begins with educating benefits decision-makers about the hidden costs and conflicts of interest embedded in traditional PBM arrangements. Many employers do not fully understand how their current PBM generates revenue from spread pricing (the difference between what the PBM charges the employer for a drug and what it pays the pharmacy), retained rebates (rebates negotiated from manufacturers that the PBM keeps rather than passing through to the employer), and affiliated pharmacy steering (directing prescriptions to PBM-owned mail-order and specialty pharmacies where the PBM captures both the PBM margin and the pharmacy margin).
"[Benefits Director Name], I'm [your name] with [PBM name], an independent, transparent pharmacy benefit manager. I'm reaching out because many employers like [company name] are discovering that their current PBM arrangements contain hidden costs that a transparent PBM model eliminates entirely.
Unlike the vertically integrated PBMs that own insurance companies, pharmacy chains, and specialty pharmacies, [PBM name] operates on a 100% pass-through model: every manufacturer rebate, every pharmacy discount, and every administrative fee flows through to [company name] with complete visibility. Our revenue comes exclusively from a disclosed per-claim administrative fee, which means our financial incentives are perfectly aligned with yours -- we both benefit when drug costs go down.
Our clients -- employers ranging from [size range] employees -- have typically seen [percentage range] reductions in total pharmacy spend in the first year after switching from a traditional PBM, driven by the elimination of spread pricing, full rebate pass-through, and formulary decisions based on clinical value rather than rebate maximization.
Would a 20-minute call next week to walk through a preliminary cost comparison based on [company name]'s pharmacy claims data make sense? I can show you exactly where the savings opportunities are in your current plan. [Name], [Title], [PBM Name], [phone]."
340B Program Administration
The 340B Drug Pricing Program is a federal program (established by Section 340B of the Public Health Service Act) that requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at significantly discounted prices (typically 25-50%+ below average wholesale price) to eligible healthcare organizations called "covered entities." Covered entities include disproportionate share hospitals (DSH hospitals that serve a high percentage of low-income patients), federally qualified health centers (FQHCs), Ryan White HIV/AIDS Program clinics, children's hospitals, critical access hospitals, sole community hospitals, and several other categories of safety-net healthcare providers.
The 340B program has grown dramatically, with approximately 13,000+ covered entity sites and over 30,000+ contract pharmacy arrangements generating an estimated $40-50+ billion in 340B drug purchases annually. The program has become a critical revenue source for many covered entities, which use the difference between the 340B acquisition cost and the reimbursement they receive from patients' insurance (the "340B margin") to fund uncompensated care, patient assistance programs, and clinical services for underserved populations.
Navigate to HRSA (Health Resources and Services Administration) 340B OPAIS (Office of Pharmacy Affairs Information System) database, which lists all registered covered entities, their 340B ID numbers, covered entity types, and contract pharmacy arrangements. Save covered entity search results and contract pharmacy listings as HTML or download as CSV. Upload to Email Extractor to extract pharmacy director, 340B program coordinator, CFO, and compliance officer email addresses from HRSA 340B covered entity databases for 340B program administration and compliance services outreach.
Related Guides
- Email Strategies for Commercial Independent Pharmacy and Compounding Pharmacy Operations
- Data Cleaning for Commercial Pharmacy and Pharmaceutical Distributor Databases
- Cold Email for Employee Benefits Brokers
- Email Strategies for Commercial Behavioral Health and Addiction Treatment Centers
- Email Verification for Commercial Staffing and Recruitment Databases
